The healing effect of licorice extract in acetic acid-induced ulcerative colitis in rat model

Comparative Clinical Pathology

Volumn 21, Issue 6, 2012, Pages 1139-1144

  Takhshid, M A ^a   Mehrabani, Davood ^b   Ai, Jafar ^b,c,d   Zarepoor, M ^e  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acetic acid; Healing; Licorice; Rat; Ulcerative colitis

Indexed keywords

EID: 85027933564     PISSN: 16185641     EISSN: 1618565X     Source Type: Journal    
DOI: 10.1007/s00580-011-1249-9     Document Type: Article

References (33)

1. Strober W, Ludviksson BR, Fuss IJ (1998) The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med 128: 848-856.
2. Williams JG, Hughes LE, Hallett MB (1990) Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 31: 187-193.
3. Grisham MB, Volkmer C, Tso P, Yamada T (1991) Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 101: 540-547.
4. Grisham MB, Gaginella TS, von Ritter C, Tamai H, Be RM, Granger DN (1990) Effects of neutrophils derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability. Inflammation 14: 531-542.
5. Oz HS, Chen TS, McClain CJ, Villiers WJ (2005) Antioxidants as novel therapy in a murine model of colitis. J Nutr Biochem 16: 297-304.
6. Kurutas EB, Cetinkaya A, Bulbuloglu E, Kantarceken B (2005) Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-super oxide dismutase and plasma malondialdehyde levels in experimental colitis. Mediators Inflamm 6: 390-394.
7. Joshi R, Kumar S, Unnikrishnan M, Mukherjee T (2005) Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity. Free Radic Res 39: 1163-1172.
8. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270: 286-290.
9. Mehrabani D, Tabei SZ, Heydari ST, Shamsina SJ, Shokrpour N, Amini M, Masoumi SJ, Julaee H, Farahmand M, Manafi A (2008) Cancer occurrence in Fars Province, Southern Iran. Iran Red Crescent Med J 10: 314-422.
10. Wang GS, Han ZW (1993) The protective action of glycyrrhiza flavonoids against carbon tetrachloride hepatotoxicity in mice. Yao Xue Xue Bao 28: 572-576.
11. Asl MN, Hosseinzadeh H (2008) Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22: 709-724.
12. Haraguchi H, Ishikawa H, Mizutani K, Tamura Y, Kinoshita T (1998) Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med Chem 6: 339-347.
13. Di Mambro VM, Fonseca MJ (2005) Assays of physical stability and antioxidant activity of a topical formulation added with different plant extract. J Pharm Biomed Anal 37: 287-295.
14. MacPherson BR, Pfeiffer CJ (1978) Experimental production of diffuse colitis in rats. Digestion 17(2): 135-150.
15. Millar AD, Rampton DS, Chander CL (1996) Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39: 407-415.
16. Cameron J, Grant Gall D, Wallace JL (1995) Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol 268: 622-630.
17. Appleyard CB, Wallace JL (1995) Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 269: 119-125.
18. Fabia R, Willen R, Ar'Rajab A, Andersson R, Ahren B, Bengmark S (1992) Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis. Eur Surg Res 24: 211-225.
19. Kojima R, Hamamoto S, Moriwaki M, Iwadate K, Ohwaki T (2001) The new experimental ulcerative colitis model in rats induced by subserosal injection of acetic acid. Nippon Yakurigaku Zasshi 118: 123-130.
20. Sekizuka E, Grisham MB, Li M, Deitch EA, Granger DN (1988) Inflammation-induced intestinal hyperemia in the rat: role of neutrophils. Gastroenterology 95: 1528-1534.
21. Kinget R, Kalala W, Vervoort L, van den Mooter G (1998) Colonic drug targeting. J Drug Target 6: 129-149.
22. Shibataa N, Tatsuharu Shimokawaa T, Jianga ZQ, Jeonga Y, Ohnoa T, Kimuraa G, Yoshikawaa Y, Kogab K, Murakamia M, Takadaa K (2000) Characteristics of intestinal absorption and disposition of glycyrrhizin in mice. Biopharm Drug Dispos 21: 95-101.
23. Baker ME (1994) Licorice and enzymes other than 11 beta-hydroxysteroid dehydrogenase: an evolutionary perspective. Steroids 59: 136-141.
24. van Rossum TGJ, Vulto AG, De Man RA, Brouwer JT, Schalm SW (1998) Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther 12: 199-205.
25. Schröfelbauer B, Raffetseder J, Hauner M, Wolkerstorfer A, Ernst W, Szolar OH (2009) Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signaling. Biochem J 421: 473-482.
26. Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T (1998) Nuclear factor-κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115: 537-569.
27. Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor-κB in inflammatory bowel disease. Gut 42: 477-484.
28. Kruidenier L, Verspaget HW (2002) Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous? Aliment Pharmacol Ther 16: 1997-2015.
29. Buffinton GD, Doe WF (1995) Depleted mucosal antioxidant defenses in inflammatory bowel disease. Free Radic Biol Med 19: 911-918.
30. Chen G, Zhu L, Liu Y, Zhou Q, Chen H, Yang J (2009) Isoliquiritigenin, a flavonoid from licorice, plays a dual role in regulating gastrointestinal motility in vitro and in vivo. Phytother Res 23: 498-506.
31. Isbrucker RA, Burdock GA (2006) Risk and safety assessment on the consumption licorice root, its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol 46: 167-192.
32. van Uum SH (2005) Liquorice and hypertension. Neth J Med 63: 119-120.
33. Bernardi M, Paola E, D'Intino F, Trevisani G, Maria A, Raggi E, Gasbarrini G (1994) Effects of prolonged ingestion of graded doses of licorice by healthy volunteers. Life Sci 55: 863-872.